HK1220218A1 - 用於制造羟乙基淀粉衍生物的方法 - Google Patents
用於制造羟乙基淀粉衍生物的方法 Download PDFInfo
- Publication number
- HK1220218A1 HK1220218A1 HK16108112.8A HK16108112A HK1220218A1 HK 1220218 A1 HK1220218 A1 HK 1220218A1 HK 16108112 A HK16108112 A HK 16108112A HK 1220218 A1 HK1220218 A1 HK 1220218A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- solution
- temperature
- hydroxyethyl starch
- iron
- value
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
- C08B31/12—Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
- C08B31/10—Alkyl or cycloalkyl ethers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/18—Oxidised starch
- C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11170761.8 | 2011-06-21 | ||
| EP11170761A EP2537866A1 (en) | 2011-06-21 | 2011-06-21 | Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1220218A1 true HK1220218A1 (zh) | 2017-04-28 |
Family
ID=44799422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16108112.8A HK1220218A1 (zh) | 2011-06-21 | 2016-07-12 | 用於制造羟乙基淀粉衍生物的方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US9181353B2 (enExample) |
| EP (2) | EP2537866A1 (enExample) |
| JP (2) | JP6370217B2 (enExample) |
| CN (2) | CN103649128B (enExample) |
| BR (1) | BR112013032901A2 (enExample) |
| CA (1) | CA2837784C (enExample) |
| CY (1) | CY1121976T1 (enExample) |
| DK (1) | DK2723774T3 (enExample) |
| ES (1) | ES2733767T3 (enExample) |
| HK (1) | HK1220218A1 (enExample) |
| HR (1) | HRP20191173T1 (enExample) |
| HU (1) | HUE044428T2 (enExample) |
| LT (1) | LT2723774T (enExample) |
| MX (1) | MX337682B (enExample) |
| PL (1) | PL2723774T3 (enExample) |
| PT (1) | PT2723774T (enExample) |
| RS (1) | RS59021B1 (enExample) |
| SI (1) | SI2723774T1 (enExample) |
| SM (1) | SMT201900430T1 (enExample) |
| TR (1) | TR201909574T4 (enExample) |
| TW (1) | TWI564010B (enExample) |
| WO (1) | WO2012175608A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6616725B2 (ja) * | 2016-03-31 | 2019-12-04 | 日本製紙株式会社 | 塗工紙用澱粉 |
| AU2020206021B2 (en) | 2019-01-10 | 2025-05-08 | Pharmacosmos Holding A/S | Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation |
| CN114286682A (zh) | 2019-02-09 | 2022-04-05 | 法码科思莫斯控股有限公司 | 治疗具有心血管不良事件风险的个体的铁缺乏以及用于治疗心房颤动的铁 |
| JP2024529536A (ja) | 2021-08-03 | 2024-08-06 | ファーマコスモス ホールディング エー／エス | コンパニオンアニマルの鉄欠乏症の治療における皮下使用のための鉄錯体化合物 |
| CN117547549A (zh) * | 2023-11-09 | 2024-02-13 | 黑龙江八一农垦大学 | 适用于犬arf的腹膜透析液与助清除剂的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3639588A (en) * | 1966-10-22 | 1972-02-01 | Fisons Pharmaceuticals Ltd | Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids |
| US4370476A (en) * | 1979-07-17 | 1983-01-25 | Usher Thomas C | Dextran polycarboxylic acids, ferric hydroxide complexes |
| GB8902894D0 (en) * | 1989-02-09 | 1989-03-30 | Fisons Plc | Compositions |
| JPH0566372A (ja) * | 1991-09-10 | 1993-03-19 | Fukui Megane Kogyo Kk | 金属製眼鏡フレーム部品の製造方法 |
| JPH0776524A (ja) * | 1993-07-13 | 1995-03-20 | Takeda Chem Ind Ltd | 動物用抗貧血剤 |
| DK172860B1 (da) * | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
| DK173138B1 (da) | 1998-11-20 | 2000-02-07 | Pharmacosmos Holding As | Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma |
| EP1762250A1 (en) * | 2005-09-12 | 2007-03-14 | Fresenius Kabi Deutschland GmbH | Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
| WO2009024518A1 (en) * | 2007-08-17 | 2009-02-26 | Akzo Nobel N.V. | Alkali metal salt of glutamic acid n,n-diacetic acid, a process to prepare such salt, and the use thereof |
| TWI469965B (zh) * | 2008-12-22 | 2015-01-21 | Ono Pharmaceutical Co | 乙炔基吲哚化合物 |
| JP5397991B2 (ja) * | 2009-04-01 | 2014-01-22 | 学校法人東京農業大学 | 乳酸菌を用いたビタミンｂ１２の定量方法 |
-
2011
- 2011-06-21 EP EP11170761A patent/EP2537866A1/en not_active Withdrawn
-
2012
- 2012-06-21 TR TR2019/09574T patent/TR201909574T4/en unknown
- 2012-06-21 BR BR112013032901A patent/BR112013032901A2/pt not_active Application Discontinuation
- 2012-06-21 PL PL12737229T patent/PL2723774T3/pl unknown
- 2012-06-21 WO PCT/EP2012/061958 patent/WO2012175608A1/en not_active Ceased
- 2012-06-21 TW TW101122208A patent/TWI564010B/zh active
- 2012-06-21 SM SM20190430T patent/SMT201900430T1/it unknown
- 2012-06-21 CA CA2837784A patent/CA2837784C/en active Active
- 2012-06-21 CN CN201280029882.3A patent/CN103649128B/zh active Active
- 2012-06-21 PT PT12737229T patent/PT2723774T/pt unknown
- 2012-06-21 MX MX2013015075A patent/MX337682B/es active IP Right Grant
- 2012-06-21 RS RS20190850A patent/RS59021B1/sr unknown
- 2012-06-21 HR HRP20191173TT patent/HRP20191173T1/hr unknown
- 2012-06-21 DK DK12737229.0T patent/DK2723774T3/da active
- 2012-06-21 SI SI201231627T patent/SI2723774T1/sl unknown
- 2012-06-21 EP EP12737229.0A patent/EP2723774B1/en active Active
- 2012-06-21 CN CN201510909616.5A patent/CN105348401A/zh active Pending
- 2012-06-21 HU HUE12737229 patent/HUE044428T2/hu unknown
- 2012-06-21 US US14/127,766 patent/US9181353B2/en active Active
- 2012-06-21 JP JP2014516345A patent/JP6370217B2/ja active Active
- 2012-06-21 ES ES12737229T patent/ES2733767T3/es active Active
- 2012-06-21 LT LTEP12737229.0T patent/LT2723774T/lt unknown
-
2015
- 2015-10-26 US US14/922,897 patent/US9631032B2/en active Active
-
2016
- 2016-07-12 HK HK16108112.8A patent/HK1220218A1/zh unknown
-
2018
- 2018-03-27 JP JP2018059264A patent/JP2018100424A/ja active Pending
-
2019
- 2019-07-03 CY CY20191100704T patent/CY1121976T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9631032B2 (en) | 2017-04-25 |
| RS59021B1 (sr) | 2019-08-30 |
| SI2723774T1 (sl) | 2019-08-30 |
| HUE044428T2 (hu) | 2019-10-28 |
| CA2837784C (en) | 2019-10-15 |
| JP2018100424A (ja) | 2018-06-28 |
| TWI564010B (zh) | 2017-01-01 |
| JP6370217B2 (ja) | 2018-08-08 |
| MX2013015075A (es) | 2014-04-14 |
| SMT201900430T1 (it) | 2019-09-09 |
| CN103649128A (zh) | 2014-03-19 |
| CY1121976T1 (el) | 2020-10-14 |
| WO2012175608A1 (en) | 2012-12-27 |
| CA2837784A1 (en) | 2012-12-27 |
| CN105348401A (zh) | 2016-02-24 |
| US20140128594A1 (en) | 2014-05-08 |
| BR112013032901A2 (pt) | 2017-01-24 |
| LT2723774T (lt) | 2019-08-12 |
| US20160046733A1 (en) | 2016-02-18 |
| CN103649128B (zh) | 2016-02-10 |
| MX337682B (es) | 2016-03-15 |
| EP2723774A1 (en) | 2014-04-30 |
| PT2723774T (pt) | 2019-07-15 |
| HRP20191173T1 (hr) | 2019-10-04 |
| PL2723774T3 (pl) | 2019-10-31 |
| US9181353B2 (en) | 2015-11-10 |
| ES2733767T3 (es) | 2019-12-02 |
| TR201909574T4 (en) | 2019-08-21 |
| EP2537866A1 (en) | 2012-12-26 |
| JP2014520188A (ja) | 2014-08-21 |
| DK2723774T3 (da) | 2019-07-15 |
| EP2723774B1 (en) | 2019-04-03 |
| TW201315474A (zh) | 2013-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1220218A1 (zh) | 用於制造羟乙基淀粉衍生物的方法 | |
| JP5225289B2 (ja) | 鉄−炭水化物錯体化合物 | |
| CN109134459B (zh) | 吡咯喹啉醌二钠盐晶体及其制备方法 | |
| CN103435715A (zh) | 寡糖及其衍生物钒配合物的制备方法及其应用 | |
| US3686397A (en) | Parenteral iron preparations | |
| CN113620883A (zh) | 一种半质子型化合物的制备方法及其产品和应用 | |
| AU2015320003C1 (en) | Iron (III) hydroxide complexes with activated glucose syrups and process for preparing same | |
| TW200538457A (en) | Aqueous solutions comprising camptothecin | |
| CN114933621A (zh) | 烟酰胺核糖的有机酸盐及其结晶形态、制备方法与用途 | |
| TW202045187A (zh) | ２－Ｏ－α－Ｄ－葡萄糖苷基－Ｌ－抗壞血酸之鉀鹽結晶及其製造方法 | |
| CN100497362C (zh) | 氨基葡萄糖酸及其衍生物的铬配合物及其制备方法和用途 | |
| KR102025140B1 (ko) | 항산화 활성 및 광분해 안정성이 증진된 흑미가루 및 이의 제조방법 | |
| CN109305938B (zh) | 诺氟沙星金属配合物及其制备方法和应用 | |
| CN103613626B (zh) | 一种环磷腺苷化合物及其环磷腺苷葡胺药物组合物 | |
| CN105362215B (zh) | 一种乳酸钙口服液及其制备方法 | |
| RS20080223A (sr) | Sinteza, karakterizacija i farmakološka svojstva bioaktivnih kompleksa bakar(ii)-jona sa pululanom i njegovim derivatima | |
| RU2660560C1 (ru) | Способ получения медьсодержащих производных сульфата арабиногалактана | |
| CN109476693A (zh) | 2-O-α-D-糖基-L-抗坏血酸金属盐、其作为抗氧化剂的用途及其粉末的制造方法 | |
| Rajagopalan et al. | Saccharin-cyclodextrin complexes-synthesis and characterization | |
| KR20230064363A (ko) | 에피갈로카테킨갈레이트 다이글루코시드 및 그 제조 방법 | |
| RU2391334C2 (ru) | Водорастворимый комплекс цис-диаминодихлорплатины (2+) с изониазидом и способ его получения | |
| IL294848A (en) | A complex of 7-deacetylforskolin and polyvinylpyrrolidone |